The strong quarterly profits Integra LifeSciences reported can be attributed to strong sales in the orthopedics and neurosciences segments.
Adjusted EBITDA was $35.5 million, up two percent from the second quarter last year.
Integra also reported a GAAP net income of $15.2 million and an adjusted net income of $20.9 million for the second quarter of 2010. The company generated $19.4 million in cash flow from operations and used $5.7 million of cash on capital expenditures.
Read the news release on the second quarter for Integra LifeSciences.
Read more coverage on Integra LifeSciences:
– Integra LifeSciences Announces Milestone for Vu a-POD Device
